Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
710 (USA) · Dr. Silva
consented 2012-09-26
AEs
3
Serious
0
Dropout signal
–
Adverse events
mild
assessed
Mild APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-01-29 (study day 126.0); relationship: POSSIBLE
moderate
assessed
Moderate COUGH — outcome: RECOVERED/RESOLVED; onset 2012-11-22 (study day 58.0); relationship: NONE
mild
assessed
Mild SHOULDER PAIN — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-01-13 (study day 110.0); relationship: NONE
Data queries
No data queries.